Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington's Disease T Lymphocytes

被引:11
|
作者
Miller, James R. C. [1 ]
Traeger, Ulrike [1 ]
Andre, Ralph [1 ]
Tabrizi, Sarah J. [1 ]
机构
[1] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England
来源
PLOS ONE | 2015年 / 10卷 / 11期
基金
英国医学研究理事会;
关键词
NF-KAPPA-B; IN-VIVO; PROLIFERATION; ACTIVATION; DIFFERENTIATION; TRANSCRIPTION; PATHWAY; ONSET;
D O I
10.1371/journal.pone.0141793
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Huntington's disease is a fatal neurodegenerative condition caused by a CAG repeat expansion in the huntingtin gene. The peripheral innate immune system is dysregulated in Huntington's disease and may contribute to its pathogenesis. However, it is not clear whether or to what extent the adaptive immune system is also involved. Here, we carry out the first comprehensive investigation of human ex vivo T lymphocytes in Huntington's disease, focusing on the frequency of a range of T lymphocyte subsets, as well as analysis of proliferation, cytokine production and gene transcription. In contrast to the innate immune system, the intrinsic phenotype of T lymphocytes does not appear to be affected by the presence of mutant huntingtin, with Huntington's disease T lymphocytes exhibiting no significant functional differences compared to control cells. The transcriptional profile of T lymphocytes also does not appear to be significantly affected, suggesting that peripheral immune dysfunction in Huntington's disease is likely to be mediated primarily by the innate rather than the adaptive immune system. This study increases our understanding of the effects of Huntington's disease on peripheral tissues, while further demonstrating the differential effects of the mutant protein on different but related cell types. Finally, this study suggests that the potential use of novel therapeutics aimed at modulating the Huntington's disease innate immune system should not be extended to include the adaptive immune system.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] QUANTIFYING MUTANT HUNTINGTIN IN HUNTINGTON'S DISEASE CSF
    Wild, Edward
    Robertson, Nicola
    Miller, James
    Traeger, Ulrike
    Haider, Salman
    Macdonald, Douglas
    Langbehn, Douglas
    Kuhn, Rainer
    Weiss, Andreas
    Tabrizi, Sarah
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
  • [2] Huntington's disease: degradation of mutant huntingtin by autophagy
    Sarkar, Sovan
    Rubinsztein, David C.
    FEBS JOURNAL, 2008, 275 (17) : 4263 - 4270
  • [3] Soluble mutant huntingtin drives early human pathogenesis in Huntington's disease
    Miguez, Andres
    Gomis, Cinta
    Vila, Cristina
    Monguio-Tortajada, Marta
    Fernandez-Garcia, Sara
    Bombau, Georgina
    Galofre, Mireia
    Garcia-Bravo, Maria
    Sanders, Phil
    Fernandez-Medina, Helena
    Poquet, Blanca
    Salado-Manzano, Cristina
    Roura, Santiago
    Alberch, Jordi
    Segovia, Jose Carlos
    Allen, Nicholas D.
    Borras, Francesc E.
    Canals, Josep M.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (08)
  • [4] Soluble mutant huntingtin drives early human pathogenesis in Huntington’s disease
    Andrés Miguez
    Cinta Gomis
    Cristina Vila
    Marta Monguió-Tortajada
    Sara Fernández-García
    Georgina Bombau
    Mireia Galofré
    María García-Bravo
    Phil Sanders
    Helena Fernández-Medina
    Blanca Poquet
    Cristina Salado-Manzano
    Santiago Roura
    Jordi Alberch
    José Carlos Segovia
    Nicholas D. Allen
    Francesc E. Borràs
    Josep M. Canals
    Cellular and Molecular Life Sciences, 2023, 80
  • [5] Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformation
    Cariulo, Cristina
    Azzollini, Lucia
    Verani, Margherita
    Martufi, Paola
    Boggio, Roberto
    Chiki, Anass
    Deguire, Sean M.
    Cherubini, Marta
    Gines, Silvia
    Marsh, J. Lawrence
    Conforti, Paola
    Cattaneo, Elena
    Santimone, Iolanda
    Squitieri, Ferdinando
    Lashuel, Hilal A.
    Petricca, Lara
    Caricasole, Andrea
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (50) : E10809 - E10818
  • [6] Mutant Huntingtin Affects Diabetes and Alzheimer's Markers in Human and Cell Models of Huntington's Disease
    Chaves, Gepoliano
    Stanley, John
    Pourmand, Nader
    CELLS, 2019, 8 (09)
  • [7] Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene
    Franich, Nicholas R.
    Hickey, Miriam A.
    Zhu, Chunni
    Osborne, Georgina F.
    Ali, Nadira
    Chu, Tiffany
    Bove, Nicholas H.
    Lemesre, Vincent
    Lerner, Renata P.
    Zeitlin, Scott O.
    Howland, David
    Neueder, Andreas
    Landles, Christian
    Bates, Gillian P.
    Chesselet, Marie-Francoise
    JOURNAL OF NEUROSCIENCE RESEARCH, 2019, 97 (12) : 1590 - 1605
  • [8] Parallel evaluation of mutant huntingtin and neurofilament light in Huntington's disease
    Byrne, L.
    Rodrigues, F.
    Johnson, E.
    De Vita, E.
    Czech, C.
    Schobel, S.
    Scahill, R.
    Heslegrave, A.
    Zetterberg, H.
    Wild, W.
    MOVEMENT DISORDERS, 2018, 33 : S370 - S374
  • [9] Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease
    Wellington, CL
    Ellerby, LM
    Gutekunst, CA
    Rogers, D
    Warby, S
    Graham, RK
    Loubser, O
    van Raamsdonk, J
    Singaraja, R
    Yang, YZ
    Gafni, J
    Bredesen, D
    Hersch, SM
    Leavitt, BR
    Roy, S
    Nicholson, DW
    Hayden, MR
    JOURNAL OF NEUROSCIENCE, 2002, 22 (18): : 7862 - 7872
  • [10] Huntington’s disease cerebrospinal fluid seeds aggregation of mutant huntingtin
    Z Tan
    W Dai
    T G M van Erp
    J Overman
    A Demuro
    M A Digman
    A Hatami
    R Albay
    E M Sontag
    K T Potkin
    S Ling
    F Macciardi
    W E Bunney
    J D Long
    J S Paulsen
    J M Ringman
    I Parker
    C Glabe
    L M Thompson
    W Chiu
    S G Potkin
    Molecular Psychiatry, 2015, 20 : 1286 - 1293